Long-Term Assets: The sum of all assets classified as non-current.
Passage Bio, Inc. (PASG) had Long-Term Assets of $18.43M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.75M |
|
-- |
|
-- |
|
$8.65M |
|
$-8.65M |
|
$0.91M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-7.75M |
|
$-8.65M |
|
$-8.47M |
|
3.18M |
|
3.18M |
|
$-2.44 |
|
$-2.44 |
|
| Balance Sheet Financials | |
$55.73M |
|
$5.16M |
|
|
Long-Term Assets |
$18.43M |
$74.16M |
|
$22.25M |
|
-- |
|
$20.80M |
|
$43.04M |
|
$31.12M |
|
$31.12M |
|
$31.12M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-25.03M |
|
$40.22M |
|
$0.01M |
|
$37.57M |
|
$52.77M |
|
$15.20M |
|
$2.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.90% |
|
-24.90% |
|
-10.45% |
|
-24.90% |
|
$9.79 |
|
$-7.51 |
|
$-7.87 |
|